PierreNTariotMD

Director, Banner Alzheimer's Institute; Research Professor of Psychiatry, University of Arizona

Dr. Tariot is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

National Institutes of Health Clinical CenterResidency, Psychiatry, 1983 - 1986
University of Wisconsin Hospitals and ClinicsResidency, Psychiatry, 1981 - 1983
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1978 - 1981
University of Rochester School of Medicine and DentistryClass of 1978

CATIE-Alzheimer's Disease Trial Start of enrollment: 2001 Mar 01
Completed
Not Applicable
Valproate in Dementia (VALID) Start of enrollment: 2003 Oct 01
Completed
Phase 3
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects Start of enrollment: 2013 Dec 01
Completed
Phase 2, Phase 3

PubMed

733 citations
Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
Yasser Iturria-Medina, Roberto C. Sotero, Paule-Joanne Toussaint, José María Mateos-Pérez, Alan C. Evans
Nature Communications. 2016-06-21
408 citations
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
Michael F. Egan, James Kost, Pierre N. Tariot, Paul S. Aisen, Jeffrey L. Cummings
The New England Journal of Medicine. 2018-05-02
109 citations
Ushering in the study and treatment of preclinical Alzheimer disease.
Jessica B. Langbaum, Adam S. Fleisher, Kewei Chen, Napatkamon Ayutyanont, Francisco Lopera
Nature Reviews. Neurology. 2013-07-01

Silver Synapses: Themes from an International Conference on Alzheimer’s DiseaseOctober 2018

A New Drug Could Slow Alzheimer’s Disease, Data ShowNovember 30th, 2022
Alzheimer's Researchers Delve into Data from Failed Crenezumab TrialAugust 5th, 2022
Landmark Alzheimer's Prevention Trial Unable to Show Significantly Slower Cognitive Decline in Inherited Form of DiseaseJune 16th, 2022
Join now to see all

Alzheimer's Prevention InitiativeNational Institute on Aging2012–Present
Trial Of Valproate To Attenuate The Progression Of ADNational Institute On Aging2001–2002
Divalproex Sodium Therapy For Agitation And Dementia In The Nursing HomeNational Institute On Aging1996–2001
Core--ClinicalNational Institute On Aging1995–2000
Geriatric Mental Health Academic AwardNational Institute Of Mental Health1988–1992